BSE Live
Oct 01, 16:01Prev. Close
1588.50
Open Price
1649.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:44Prev. Close
1585.90
Open Price
1585.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Eris Lifesciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 1,663.63 | 1,454.75 | 1,307.12 | 1,193.77 | 1,088.65 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 1,663.63 | 1,454.75 | 1,307.12 | 1,193.77 | 1,088.65 | |
Total Operating Revenues | 1,697.75 | 1,486.71 | 1,330.73 | 1,215.73 | 1,108.83 | |
Other Income | 35.51 | 34.83 | 17.26 | 28.99 | 10.00 | |
Total Revenue | 1,733.26 | 1,521.53 | 1,347.99 | 1,244.72 | 1,118.83 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 68.35 | 96.29 | 114.13 | 117.57 | 99.43 | |
Purchase Of Stock-In Trade | 474.44 | 197.02 | 113.76 | 79.59 | 111.65 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -43.54 | -13.15 | 8.50 | 2.49 | -12.57 | |
Employee Benefit Expenses | 361.92 | 331.67 | 252.52 | 222.18 | 207.02 | |
Finance Costs | 220.24 | 57.42 | 20.81 | 2.99 | 0.78 | |
Depreciation And Amortisation Expenses | 181.77 | 102.39 | 64.66 | 51.46 | 37.64 | |
Other Expenses | 350.03 | 421.06 | 336.71 | 309.90 | 285.99 | |
Total Expenses | 1,613.21 | 1,192.70 | 911.08 | 786.18 | 729.94 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 120.05 | 328.83 | 436.91 | 458.54 | 388.89 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 120.05 | 328.83 | 436.91 | 458.54 | 388.89 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 21.98 | 57.64 | 76.50 | 80.17 | 70.18 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 20.68 | -28.52 | -37.59 | -38.83 | -31.90 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 42.66 | 29.12 | 38.90 | 41.35 | 38.29 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 77.39 | 299.71 | 398.01 | 417.19 | 350.61 | |
Profit/Loss From Continuing Operations | 77.39 | 299.71 | 398.01 | 417.19 | 350.61 | |
Profit/Loss For The Period | 77.39 | 299.71 | 398.01 | 417.19 | 350.61 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 5.69 | 22.04 | 29.27 | 30.70 | 25.82 | |
Diluted EPS (Rs.) | 5.68 | 22.01 | 29.23 | 30.70 | 25.80 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 100.06 | 0.00 | 99.93 | 81.65 | 74.68 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 735.00 | 0.00 | 735.00 | 601.00 | 550.00 |
25.08.2025
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
08.08.2025
06.08.2025
Buy Eris Lifesciences; target of Rs 1975: Prabhudas Lilladher
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
05.08.2025
Eris Life Standalone June 2025 Net Sales at Rs 578.64 crore, up 26.7% Y-o-Y
20.05.2025
Eris Life Consolidated March 2025 Net Sales at Rs 705.30 crore, up 28.02% Y-o-Y
20.05.2025
Eris Life Standalone March 2025 Net Sales at Rs 404.77 crore, up 18.6% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher